Institutional Biosafety Committee (IBC)
Icahn School of Medicine Institutional Biosafety Committee monitors all laboratory activities involving recombinant DNA and synthetic DNA molecules as required by the National Institutes of Health (NIH) Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines).
The Committee reviews submissions of proposed research and evaluates the Risk Group, Biological Safety Level, and the appropriate NIH-OBA Section III designation (Research that requires notification to the Biosafety Officer alone; notification to the Committee prior to, or simultaneous with initiation of work; approval by the Committee before initiation, and approval by the Committee and the Office of Biotechnology Assessment before initiation.
IBC Form [DOC]
Schedule of Meetings for 2016
IBC meets the third Thursday of every other month at 2:30 p.m. in Annenberg 21-76. This year's meetings are listed below:
- January 21
- March 17
- May 19
- July 21
- September 15
- November 17
Please forward Biosafety Risk Assessment Forms and Sponsor's Brochure three full weeks before the meeting date by Fax to: 212-241-6695 or by scanned attachment to email@example.com.